Status:
UNKNOWN
Using Big Data to Conduct Innovative Cardiovascular Clinical Trials
Lead Sponsor:
Institute for Clinical Evaluative Sciences
Collaborating Sponsors:
Knowledge Translation Program of St. Michael's Hospital
Heart and Stroke Foundation of Ontario
Conditions:
Cardiovascular Diseases
Cardiovascular Risk Factor
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
Traditional randomized clinical trials (RCTs) have provided extremely valuable information on medical therapies and procedures that have changed the way heart diseases are treated. However, despite th...
Detailed Description
An estimated 19,500 cardiac events could be prevented each year in Canada by use of statin therapy as recommended in the Canadian Cardiovascular Society's Lipid Guidelines. Despite substantial evidenc...
Eligibility Criteria
Inclusion
- Community with CVD incidence rates higher than the Ontario provincial average
- Community with a population size greater than 5,000 40 to 75 year olds
- Community with at least 1,000 66 to 75 year olds
- Community with 20 to 130 active and practicing family physicians
Exclusion
- Patients with established CVD within each community
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
500000 Patients enrolled
Trial Details
Trial ID
NCT04067297
Start Date
October 1 2019
End Date
March 31 2025
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICES
Toronto, Ontario, Canada, M4N3M5